Global Non-melanoma Skin Cancer Market 2022-2026

Description

List of Tables

Technavio has been monitoring the non-melanoma skin cancer market and it is poised to grow by $ 180.97 million during 2022-2026, accelerating at a CAGR of 5.76% during the forecast period. Our report on the non-melanoma skin cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by NMSC coverage and support, increase in awareness about skin cancer, and initiatives by organizations.

The non-melanoma skin cancer market analysis includes the type segment and geographic landscape.

Technavio's non-melanoma skin cancer market is segmented as below:

By Type

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing incidence of NMSC as one of the prime reasons driving the non-melanoma skin cancer market growth during the next few years. Also, the consideration of surgery as the first-line curative approach for NMSC and high off-label use of topical treatments for NMSC will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on non-melanoma skin cancer market covers the following areas:

Non-melanoma skin cancer market sizing
Non-melanoma skin cancer market forecast
Non-melanoma skin cancer market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-melanoma skin cancer market vendors that include 3M Corp., Almirall SA, Amgen Inc., Bausch Health Companies Inc., Bristol Myers Squibb Co., Elekta AB, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, iCAD Inc., Merck and Co. Inc., Mylan N.V, Novartis AG, Pfizer Inc., Sensus Healthcare Inc., Sun Pharmaceutical Industries Ltd., Varian Medical Systems Inc., and Vidac Pharma. Also, the non-melanoma skin cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73279

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 BCC - Market size and forecast 2021-2026
Exhibit 28: Chart on BCC - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on BCC - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on BCC - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on BCC - Year-over-year growth 2021-2026 (%)
5.4 SCC - Market size and forecast 2021-2026
Exhibit 32: Chart on SCC - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on SCC - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on SCC - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on SCC - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 38: Chart on Market share by geography 2021-2026 (%)
Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 China - Market size and forecast 2021-2026
Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity by geography
Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 3M Corp.
Exhibit 89: 3M Corp. - Overview
Exhibit 90: 3M Corp. - Business segments
Exhibit 91: 3M Corp. - Key news
Exhibit 92: 3M Corp. - Key offerings
Exhibit 93: 3M Corp. - Segment focus
10.4 Almirall SA
Exhibit 94: Almirall SA - Overview
Exhibit 95: Almirall SA - Product / Service
Exhibit 96: Almirall SA - Key news
Exhibit 97: Almirall SA - Key offerings
10.5 Bausch Health Companies Inc.
Exhibit 98: Bausch Health Companies Inc. - Overview
Exhibit 99: Bausch Health Companies Inc. - Business segments
Exhibit 100: Bausch Health Companies Inc. - Key news
Exhibit 101: Bausch Health Companies Inc. - Key offerings
Exhibit 102: Bausch Health Companies Inc. - Segment focus
10.6 Bristol Myers Squibb Co.
Exhibit 103: Bristol Myers Squibb Co. - Overview
Exhibit 104: Bristol Myers Squibb Co. - Product / Service
Exhibit 105: Bristol Myers Squibb Co. - Key offerings
10.7 Elekta AB
Exhibit 106: Elekta AB - Overview
Exhibit 107: Elekta AB - Business segments
Exhibit 108: Elekta AB - Key news
Exhibit 109: Elekta AB - Key offerings
Exhibit 110: Elekta AB - Segment focus
10.8 F. Hoffmann La Roche Ltd.
Exhibit 111: F. Hoffmann La Roche Ltd. - Overview
Exhibit 112: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 113: F. Hoffmann La Roche Ltd. - Key news
Exhibit 114: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 115: F. Hoffmann La Roche Ltd. - Segment focus
10.9 Mylan N.V
Exhibit 116: Mylan N.V - Overview
Exhibit 117: Mylan N.V - Product / Service
Exhibit 118: Mylan N.V - Key offerings
10.10 Sun Pharmaceutical Industries Ltd.
Exhibit 119: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 120: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 121: Sun Pharmaceutical Industries Ltd. - Key offerings
10.11 Varian Medical Systems Inc.
Exhibit 122: Varian Medical Systems Inc. - Overview
Exhibit 123: Varian Medical Systems Inc. - Business segments
Exhibit 124: Varian Medical Systems Inc. - Key offerings
Exhibit 125: Varian Medical Systems Inc. - Segment focus
10.12 Vidac Pharma
Exhibit 126: Vidac Pharma - Overview
Exhibit 127: Vidac Pharma - Product / Service
Exhibit 128: Vidac Pharma - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 129: Inclusions checklist
Exhibit 130: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 131: Currency conversion rates for US$
11.4 Research methodology
Exhibit 132: Research methodology
Exhibit 133: Validation techniques employed for market sizing
Exhibit 134: Information sources
11.5 List of abbreviations
Exhibit 135: List of abbreviations